From the aDepartment of Radiation Oncology, University of Michigan; bUniversity of Michigan Medical School; and the cDepartment of Biostatistics, dDepartment of Health Behavior & Health Education, eDivision of Hematology & Oncology, and fDivision of General Medicine, University of Michigan, Ann Arbor, Michigan.
J Natl Compr Canc Netw. 2014 Feb;12(2):204-12. doi: 10.6004/jnccn.2014.0021.
Physician attitudes toward and lack of familiarity with guidelines have been identified as potential barriers to adherence in general, but little is known about their attitudes toward and use of cancer management guidelines specifically. This study surveyed 1500 surgeons and medical oncologists drawn from the AMA Masterfile in 2012. This report describes and compares the attitudes of medical oncologists and surgeons who treat patients with breast cancer regarding guidelines in general and the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) in particular, and their familiarity, use, and compliance with these guidelines. Of 896 respondents, responses were analyzed from the 766 who had seen at least one new patient with breast cancer in the past year. Mean participant age was 52 years; 25% worked in a teaching setting. Attitudes toward guidelines were generally favorable. Medical oncologists were more likely than surgeons to be aware that NCCN issues guidelines for cancer management (100% vs 74%; P<.001) and more likely to state that these guidelines generally influence their decisions (96% vs 70%; P<.001). Among those aware of NCCN Guidelines, 96% reported that they often agreed with NCCN recommendations, and 75% reported that almost all of their breast cancer treatment recommendations were consistent with these guidelines. Still, most providers (77%) also reported that they refer one-fourth or fewer of their patients with breast cancer to the NCCN Guidelines for Patients. Attitudes toward physician-directed cancer management guidelines are generally positive, and they are frequently used. However, existing guidelines seem to have greater visibility to the medical oncology audience than to surgeons, and patient versions are infrequently recommended.
医生对指南的态度和不熟悉一直被认为是普遍遵守的潜在障碍,但对他们对癌症管理指南的具体态度和使用知之甚少。本研究于 2012 年从 AMA 主文件中抽取了 1500 名外科医生和肿瘤内科医生进行了调查。本报告描述并比较了治疗乳腺癌患者的肿瘤内科医生和外科医生对一般指南和 NCCN 肿瘤临床实践指南(NCCN 指南)的态度,以及他们对这些指南的熟悉程度、使用情况和遵守情况。在 896 名应答者中,对过去一年至少见过一名新的乳腺癌患者的 766 名应答者的回答进行了分析。参与者的平均年龄为 52 岁;25%的人在教学环境中工作。对指南的态度普遍较为积极。肿瘤内科医生比外科医生更有可能意识到 NCCN 发布癌症管理指南(100%对 74%;P<.001),更有可能表示这些指南通常会影响他们的决策(96%对 70%;P<.001)。在意识到 NCCN 指南的人群中,96%的人报告说他们经常同意 NCCN 的建议,75%的人报告说他们几乎所有的乳腺癌治疗建议都与这些指南一致。尽管如此,大多数提供者(77%)还报告说,他们只向四分之一或更少的乳腺癌患者推荐 NCCN 指南。医生指导的癌症管理指南的态度普遍较为积极,且经常被使用。然而,现有的指南似乎对肿瘤内科医生的可见度高于外科医生,而且很少推荐患者版本。